Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Enrollment remains ongoing for the phase 3 clinical study of avatrombopag for the treatment of patients with CIT.
Lead Product(s): Avatrombopag Maleate
Therapeutic Area: Hematology Product Name: Undisclosed
Highest Development Status: Phase IIIProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable January 13, 2020